Muutke küpsiste eelistusi

Market-Driven Evolution: Redesigning Lifeforms to What End? Unabridged edition [Kõva köide]

  • Formaat: Hardback, 185 pages, kõrgus x laius: 212x148 mm
  • Ilmumisaeg: 01-Jul-2026
  • Kirjastus: Cambridge Scholars Publishing
  • ISBN-10: 1036472825
  • ISBN-13: 9781036472825
Teised raamatud teemal:
  • Kõva köide
  • Hind: 62,99 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 83,99 €
  • Säästad 25%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
Market-Driven Evolution: Redesigning Lifeforms to What End? Unabridged edition
  • Formaat: Hardback, 185 pages, kõrgus x laius: 212x148 mm
  • Ilmumisaeg: 01-Jul-2026
  • Kirjastus: Cambridge Scholars Publishing
  • ISBN-10: 1036472825
  • ISBN-13: 9781036472825
Teised raamatud teemal:
Expressions of life in its myriad forms were once driven solely by natural selection in both competition and cooperation with other lifeforms bounded by environmental conditions. Generations of human intervention have yielded to what Charles Darwin called, "artificial selection", often overriding natural selection. This book focuses on how evolution is now governed increasingly by human preferences which are driven by market forces. Recent transformational events in the bioethical, legal, and technological spheres are covered here. The range of emerging biotech issues in these chapters are but a sample of potential opportunities and consequences with any number of other wild card scenarios left to the imagination of the reader. Hence, this is why the title of the book is a question.
Timothy E. Dolan is currently on the faculty of American University in Washington D.C. where he teaches foresight and leadership development and foresight and risk management. He has written nearly 40 scholarly pieces in numerous academic journals and books on topics ranging from leadership theory to biotech. His latest book explores the impacts, for better and possibly for worse, of the biotech revolution.